Frail and on a Weight-Loss Drug? What a 17,604-Person Heart Study Found
If you or a parent is frail, you may worry a weight-loss drug could make things worse. A new analysis of 17,604 heart patients found frailty was more likely to improve on semaglutide. Here are the results, the caveats, and how to protect strength.
Less Chemo, Better Results for Kids With High-Risk Leukemia? What Families Should Know
A large new trial swapped two rounds of intense chemo for an immune drug called blinatumomab in 709 children with high-risk leukemia. Here are the results, the trade-offs, what it could mean, and three questions to bring to the care team.
Hidden Artery Plaque Is More Common Than You Think. Here’s What to Ask For.
More than half of healthy adults in the REACT study already had plaque in their arteries, and risk calculators missed most of it. Here is what the study found, what it does not prove, and the three questions I would bring to your next visit.
Should You Get an Lp(a) Test? What a New Lancet Study Means for Your Care at ThriveMed
Most cholesterol panels skip lipoprotein(a), an inherited heart risk marker. Here is what a new Lancet study of Kylo-11 found, what it does not prove yet, and how to ask for the Lp(a) lab at ThriveMed.
BEATING DEPRESSION AND ANXIETY WITH ANNE TAYLOR | SAMASTA TV
Anxiety is a tough beast to beat, which makes having a simple solution, such as music so important.
Is this the beginning of the end of Type II Diabetes?
Is this the beginning of the end of Type II Diabetes?
The cure to 80% of your chronic illnesses
3 simple tools that you can use in less than 3 minutes to spearhead the future of healthcare